Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia - the find-AF study

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Wachter, Rolf ^a   Lahno, Rosine ^a   Haase, Beatrice ^a   Weber Krüger, Mark ^a   Seegers, Joachim ^a   Edelmann, Frank ^a   Wohlfahrt, Janin ^a   Gelbrich, Götz ^b   Görlitz, Anke ^a   Kermer, Pawel ^a   Vollmann, Dirk ^a   Hasenfuß, Gerd ^a   Gröschel, Klaus ^c   Stahrenberg, Raoul ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO ATRIAL NATRIURETIC PEPTIDE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; MALE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PAROXYSMAL ATRIAL FIBRILLATION; PATIENT IDENTIFICATION; PATIENT SELECTION; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SINUS RHYTHM; BLOOD; KINETICS; TIME;

AGED; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; FEMALE; HUMANS; KINETICS; MALE; NATRIURETIC PEPTIDES; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84859590046     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034351     Document Type: Article

References (22)

1. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, et al. (2001) Risk factors, outcome, and treatment in subtypes of ischemic stroke: The german stroke data bank. Stroke 32: 2559-2566.
2. Wolf PA, Abbott RD, Kannel WB, (1991) Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke 22: 983-988.
3. Hart RG, Halperin JL, Pearce LA, Anderson DC, Kronmal RA, et al. (2003) Lessons from the stroke prevention in atrial fibrillation trials. Ann Intern Med 138: 831-838.
4. Crystal E, Connolly SJ, (2004) Role of oral anticoagulation in management of atrial fibrillation. Heart 90: 813-817.
5. Stahrenberg R, Weber-Krüger M, Seegers J, Edelmann F, Lahno R, et al. (2010) Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous Holter monitoring in patient with cerebral ischemia presenting in sinus rhythm. Stroke 41: 2884-2888.
6. Sinha AM, Diener HC, Morillo C, Sanna T, Bernstein RA, et al. (2010) Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am Heart J 160: 36-41.e1.
7. Schnabel RB, Larson MG, Yamamoto JF, Sullivan LM, Pencina MJ, et al. (2010) Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 121: 200-207.
8. Wazni OM, Martin DO, Marrouche NF, Latif AA, Ziada K, et al. (2004) Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 110: 124-127.
9. Silvet H, Young-Xu Y, Walleigh D, (2003) Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 92: 1124-1127.
10. Nakamura M, Niinuma H, Chiba M, Ueshima K, Arakawa N, et al. (1997) Effect of the Maze procedure for atrial fibrillation on atrial and brain natriuretic peptide. Am J Cardiol 79: 966-970.
11. Vinch CS, Rashkin J, Logsetty G, Tighe DA, Hill JC, et al. (2004) Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm. Cardiology 102: 188-193.
12. Wozakowska-Kaplon B, (2004) Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 93: 1555-1558.
13. Naya T, Yukiiri K, Hosomi N, Takahashi T, Ohkita H, et al. (2008) Brain natriuretic peptide as a surrogate marker for cardioembolie stroke with paroxysmal atrial fibrillation. Cerebrovasc Dis 26: 434-440.
14. Hou JL, Gao K, Li M, Ma JY, Shi YK, et al. (2008) Increased N-terminal pro-brain natriuretic peptide level predicts atrial fibrillation after surgery for esophageal carcinoma. World J Gastroenterol 14: 2582-2585.
15. Patton KK, Ellinor PT, Heckbert SR, Christenson RH, DeFilippi C, et al. (2009) N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation 120: 1768-1774.
16. Okada Y, Shibazaki K, Kimura K, Iguchi Y, Miki T, (2010) Brain natriuretic peptide as a predictor of delayed atrial fibrillation after ischaemic stroke and transient ischaemic attack. Eur J Neurol 17: 326-331.
17. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T, (2000) Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 6: 92-96.
18. Giannakoulas G, Hatzitolios A, Karvounis H, Koliakos G, Charitandi A, et al. (2005) N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke. Angiology 56: 723-730.
19. Omran H, Jung W, Rabahieh R, Schimpf R, Wolpert C, et al. (1997) Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study. J Am Coll Cardiol 29: 131-138.
20. Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M, et al. (2007) Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: A systematic review. Stroke 38: 2935-2940.
21. Hohnloser SH, Pajitnev D, Pogue J, Healey S, Pfeffer MA, et al. (2007) Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy. An ACTIVE W substudy. J Am Coll Cardiol 50: 2156-2161.
22. Healey JS, Hart RG, Pogue J, Pfeffer MA, Hohnloser SH, et al. (2008) Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Stroke 39: 1482-1486.